Patents for C07D 231 - Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings (25,550) |
---|
08/02/2006 | EP1684762A2 Urea derivatives as kinase modulators |
08/02/2006 | EP1280778B1 Benzoylpyrazols and their use as herbicides |
08/02/2006 | EP1072576B1 Fluorinating agent, process for producing the same, and use thereof |
08/02/2006 | CN1812973A Indazole compounds useful as protein kinase inhibitors |
08/02/2006 | CN1812967A Cathepsin cysteine protease inhibitors |
08/02/2006 | CN1812966A N-alkynyl-2- (substituted aryloxy) alkylthioamide derivatives as fungicides |
08/02/2006 | CN1812959A Method for producing difluoro-acetyl-acetic acid alkylesters |
08/02/2006 | CN1812782A Pyrazolidinedione derivatives and their use as platelet aggregation inhibitors |
08/01/2006 | US7084178 Antiamyloid phenylsulfonamides: N-cycloalkylcarboxamides derivatives |
08/01/2006 | US7084163 Applying to plants |
08/01/2006 | US7083865 Containing rubrene compound and dopes; applying voltage |
08/01/2006 | CA2276945C Tricyclic-substituted pyrazolyl benzenesulfonamides and pharmaceutical compositions thereof |
08/01/2006 | CA2189456C Substituted aromatic thiocarboxylic acid amides and their use as herbicides |
07/27/2006 | WO2006077070A1 Chemical compounds, process for their preparation and use thereof |
07/27/2006 | WO2006053555A3 Pyrazol-3-one and/or pyridazin-3-one derivatives used as inhibitors of lysyl oxidase |
07/27/2006 | WO2006034315A3 Heterocyclic derivatives for the treatment of diseases mediated by stearoyl-coa desaturase enzymes |
07/27/2006 | WO2006015263A3 Lonidamine analogs |
07/27/2006 | WO2005120498A3 Method for synthesis of lonidamine and related indazole derivatives |
07/27/2006 | US20060167270 5-substituted 2h-pyrazone-3-carbixylic acid derivatives as antilipolytic agents for the treatment of metabolic-related disorders such as dyslipidemia |
07/27/2006 | US20060167053 e.g. 3-(6-ethanesulfonylpyridin-3-yloxy)-5-(2-hydroxy-1-methyl-ethoxy)-N-(1-methyl-1H-pyrazol-3-yl)benzamide; glucokinase activator; antidiabetic agent; obesity, insulin resistance |
07/27/2006 | US20060167000 veterinary medicine; neurodegenerative diseases; Alzheimers's Disease |
07/27/2006 | US20060166829 N-Heterocycl phenyl-substituted cyclic ketoenols |
07/27/2006 | CA2587455A1 Substituted pyrazoles, compositions thereof, and their use as pesticides |
07/26/2006 | EP1682538A1 Biaryl linked hydroxamates: preparation and pharmaceutical applications |
07/26/2006 | EP1682537A1 Modulators of cellular adhesion |
07/26/2006 | EP1682516A2 Immobilized n-substituted tricyclic 3-aminopyrazoles for the identification of biomolecular targets |
07/26/2006 | EP1682515A1 Method for the production of fluoromethyl-substituted heterocycles |
07/26/2006 | EP1682494A1 Aralkyl amines as cannabinoid receptor modulators |
07/26/2006 | EP1682138A2 Heterocyclic inhibitors of mek and methods of use thereof |
07/26/2006 | CN1809559A Pyrazole derivatives as phosphodiesterase 4 inhibitors |
07/26/2006 | CN1809531A Aminopropanol derivatives as sphingosine-1-phosphate receptor modulators |
07/26/2006 | CN1809347A Selective spirocyclic glucocorticoid receptor modulators |
07/26/2006 | CN1266112C Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
07/20/2006 | WO2006076706A1 Cinnamide and hydrocinnamide derivatives with raf-kinase inhibitory activity |
07/20/2006 | WO2006076202A1 Heterocyclic carboxamide compounds as steroid nuclear receptors ligands |
07/20/2006 | WO2006075955A1 Pyrazolyl acylsulfonamide derivatives as endothelin converting enzyme inhibitors and useful in the treatment of chronic obstructive pulmonary disease |
07/20/2006 | WO2006075638A1 Novel heteroaryl derivative |
07/20/2006 | WO2006060762A3 Pyrazole derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto |
07/20/2006 | WO2006052546A3 Pyrazolylmethyl heteroaryl derivatives |
07/20/2006 | WO2006007497A3 Prodrugs of mitotic kinesin inhibitors |
07/20/2006 | US20060160858 Administering N-Cyclopropyl-2-{3-[(E)-2-(4-methyl-pyridin-2-yl)-vinyl]-1H-indazol-6-ylamino}-benzamide for treating ophthalmic disease which is age related macular degeneration, diabetic retinopathy, or neovascular glaucoma |
07/20/2006 | US20060160856 Diarylurea derivatives and their use as chloride channel blockers |
07/20/2006 | US20060160773 Combretastatin derivatives with cytotoxic action |
07/20/2006 | CA2594860A1 Cinnamide and hydrocinnamide derivatives with raf-kinase inhibitory activity |
07/20/2006 | CA2593156A1 Heterocyclic carboxamide compounds as steroid nuclear receptors ligands |
07/19/2006 | EP1680411A2 Modulators of atp-binding cassette transporters containing cycloalkyl or pyranyl groups |
07/19/2006 | EP1680407A1 Isopentyl carboxanilides for combating undesired micro-organisms |
07/19/2006 | EP1680109A1 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same |
07/19/2006 | EP1299361B1 Pyrazole derivatives |
07/19/2006 | CN1805950A Method for preparing fused oxazinones |
07/19/2006 | CN1805744A New n-hydroxy-4-(3-phenyl-5-methyl-isoxazole-4-yl)-benzenesulfonamide solvates |
07/18/2006 | US7078565 Benzamide derivatives as antagonists of orexin receptors |
07/18/2006 | US7078531 Process for obtaining enantiomers of thienylazolylalcoxyethanamines |
07/18/2006 | US7078426 Central nervous system disorders |
07/18/2006 | US7078425 4-(2-substituted aminocarbonyl-2-substituted aminoethyl)-7-carboxymethoxy- indole, indazole, indoline, benzotriazole or benzoimidazole derivatives, e.g., 4-[2-Benzenesulfonylamino-2-(4-phenyl-butylcarbamoyl)-ethyl]-1H-indazol-7-yloxy}-acetic acid; treating or preventing Type II Diabetes Mellitus |
07/18/2006 | US7078421 Substituted phenylacetic acids |
07/13/2006 | WO2006074330A2 Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme |
07/13/2006 | WO2006072785A2 Base stable ionic liquids |
07/13/2006 | WO2006072350A1 Cyanoguanidine-substituted pyrazolines |
07/13/2006 | US20060154988 intracellular inhibition of bacterial polypeptide deformylase in gramnegative bacteria, |
07/13/2006 | US20060154923 N-phenyl-3-cyclopropylpyrazole-4-carbonitriles as ectoparasiticidal agents |
07/13/2006 | US20060154897 Ophthalmic compositions for treating ocular hypertension |
07/13/2006 | CA2594116A1 Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme |
07/13/2006 | CA2588627A1 Novel bicyclic heterocyclic compounds, process for their preparation and compositions containing them |
07/12/2006 | EP1679308A1 Novel indazole derivative |
07/12/2006 | EP1678143A2 N-substituted pyrazolyl carboxanilides |
07/12/2006 | EP1678142A1 Hexyl carboxanilides and their use for controlling undesirable micro-organisms |
07/12/2006 | EP1678141A1 1,3-dimethylbutyl carboxanilides for controlling undesirable micro-organisms |
07/12/2006 | EP1678119A1 Method for producing 2-dihaloacyl-3-amino-acrylic acid esters and 3-dihalomethyl-pyrazole-4-carboxylic acid esters |
07/12/2006 | CN1802373A Pyrazoloisoquinoline derivatives as kinase inhibitors |
07/12/2006 | CN1800185A Substituted sulfonamide compounds, process for their use as medicament for the treatment of CNS disorders, obesity and type II diabetes. |
07/11/2006 | US7074867 Ion conducting polymers |
07/11/2006 | US7074805 Especially isoquinolin-5-ylurea derivatives; treating pain, inflammatory thermal hyperalgesia, urinary incontinence and bladder overactivity. |
07/11/2006 | CA2168447C Compounds and methods for inhibition of hiv and related viruses |
07/06/2006 | WO2006071730A1 Pyrazolone compounds as metabotropic glutamate receptor agonists for the treatment of neurological and psychiatric disorders |
07/06/2006 | WO2006070878A1 Carboxylic acid derivative or salt thereof |
07/06/2006 | WO2006069809A1 Substituted indazolyl sulfonamide and 2,3-dihydro-indolyl sulfonamide compounds, their preparation and use in medicaments |
07/06/2006 | WO2006069808A2 Nitro-substituted phenyl-piperazine compounds, their preparation and use in medicaments |
07/06/2006 | WO2006069807A1 Substituted phenyl-piperazine compounds, their preparation and use in medicaments |
07/06/2006 | WO2006069766A1 Process for obtaining enantiomers of cizolirtine |
07/06/2006 | WO2006069656A1 Fused bicyclic carboxamide derivatives for use as cxcr2 inhibitors in the treatment of inflammation |
07/06/2006 | WO2005105096A3 Fused heterocyclic compounds |
07/06/2006 | US20060149091 Method for producing difluoro-acetyl-acetic acid alkylesters |
07/06/2006 | US20060148876 Nr3b1 nuclear receptor binding 3-substituted pyrazoles |
07/06/2006 | US20060148858 1, 2-Azole derivatives with hypoglycemic and hypolipidemic activity |
07/06/2006 | US20060148817 Pyrazole compounds |
07/06/2006 | DE102004061751A1 Cyanoguanidin-substituierte Pyrazoline Cyanoguanidino substituted pyrazolines |
07/06/2006 | CA2592858A1 Substituted indazolyl sulfonamide and 2,3-dihydro-indolyl sulfonamide compounds, their preparation and use in medicaments |
07/06/2006 | CA2592852A1 Nitro-substituted phenyl-piperazine compounds, their preparation and use in medicaments |
07/06/2006 | CA2592832A1 Substituted phenyl-piperazine compounds, their preparation and use in medicaments |
07/06/2006 | CA2592514A1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
07/06/2006 | CA2592430A1 Fused bicyclic carboxamide derivatives for use as cxcr2 inhibitors in the treatment of inflammation |
07/06/2006 | CA2591003A1 Pyrazolone compounds as metabotropic glutamate receptor agonists for the treatment of neurological and psychiatric disorders |
07/05/2006 | EP1676842A1 Nitro-substituted phenyl-piperazine compounds, their preparation and use in medicaments |
07/05/2006 | EP1676841A1 Substitited indazolyl sulfonamide and 2,3-dihydro-indolyl sulfonamide compounds, their prepartion and use in medicaments |
07/05/2006 | EP1676834A1 Fused bicyclic carboxamide derivates for use as CXCR2 inhibitors in the treatment of inflammation |
07/05/2006 | EP1675844A1 Phenyl carboxamide and sulfonamide derivatives for use as 11-beta-hydroxysteroid dehydrogenase |
07/05/2006 | EP1675832A1 Heterocyclyl compounds |
07/05/2006 | EP1675587A2 Derivatives of n-(1h-indazolyl)- and n-(1h-indolyl)-urea as well as related compounds as modulators of the vanilloid-1 receptor (vr1) for the treatment of pain |
07/05/2006 | EP1675585A2 Large conductance calcium-activated k channel opener |